Publication | Closed Access

Cucurbitacin E glucoside alleviates concanavalin A-induced hepatitis through enhancing SIRT1/Nrf2/HO-1 and inhibiting NF-ĸB/NLRP3 signaling pathways

InflammationHepatologyViral HepatitisLiver PhysiologyMedicineImmunologyNf-ĸb/nlrp3 Signaling PathwaysHepatitisCucurbitacin E GlucosideConcanavalin A-induced HepatitisHepatotoxicityLiver DiseasePharmacologyCell SignalingDrug-induced Liver Injury